Efficacy and Safety of Rivaroxaban versus Warfarin in Patients Taking Non-dihydropyridine Calcium Channel Blockers: Results From the ROCKET AF Trial

Jeffrey B. Washam, Anne S. Hellkamp, Yuliya Lokhnygina, Jonathan P. Piccini, Scott D. Berkowitz, Christopher C. Nessel, Richard C. Becker, Guenter Breithardt, Keith A. Fox, Jonathan L. Halperin, Graeme J. Hankey, Kenneth W. Mahaffey, Daniel E. Singer, Manesh R. Patel

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Number of pages5
JournalCirculation
Volume132
Publication statusPublished - 10 Nov 2015
EventScientific Sessions and Resuscitation Science Symposium of the American-Heart-Association (AHA) - Orlando
Duration: 7 Nov 201511 Nov 2015

Cite this

Washam, J. B., Hellkamp, A. S., Lokhnygina, Y., Piccini, J. P., Berkowitz, S. D., Nessel, C. C., Becker, R. C., Breithardt, G., Fox, K. A., Halperin, J. L., Hankey, G. J., Mahaffey, K. W., Singer, D. E., & Patel, M. R. (2015). Efficacy and Safety of Rivaroxaban versus Warfarin in Patients Taking Non-dihydropyridine Calcium Channel Blockers: Results From the ROCKET AF Trial. Circulation, 132.